Laurent Fraisse
Director/Board Member at GENOWAY
Laurent Fraisse active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENOWAY | Director/Board Member | - | - |
Evotec (France) SAS
 Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Chief Tech/Sci/R&D Officer | 2018-06-30 | - |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Director/Board Member | - | - |
Career history of Laurent Fraisse
Former positions of Laurent Fraisse
| Companies | Position | Start | End |
|---|---|---|---|
| SANOFI | Chief Tech/Sci/R&D Officer | - | - |
| Corporate Officer/Principal | - | - |
Training of Laurent Fraisse
| Institut National Polytechnique de Toulouse | Doctorate Degree |
Statistics
International
| France | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GENOWAY | Health Technology |
| SANOFI | Health Technology |
| Private companies | 2 |
|---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Commercial Services |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Health Technology |
- Stock Market
- Insiders
- Laurent Fraisse
- Experience
